CAH
Cardinal Health, Inc.

3,326
Mkt Cap
$59.61B
Volume
1.65M
52W High
$215.48
52W Low
$120.72
PE Ratio
31.76
CAH Fundamentals
Price
$210.37
Prev Close
$212.45
Open
$210.48
50D MA
$205.13
Beta
0.32
Avg. Volume
2.13M
EPS (Annual)
$6.45
P/B
-17.39
Rev/Employee
$3.86M
Loading...
Loading...
News
all
press releases
Will Robust Adult Nutrition Business Performance Fuel ABT's Q4 Earnings?
ABT heads into Q4 earnings with adult nutrition in focus, as Ensure and Glucerna launches are expected to support modest segment growth.
Zacks·2d ago
News Placeholder
More News
News Placeholder
QRG Capital Management Inc. Decreases Holdings in Cardinal Health, Inc. $CAH
QRG Capital Management Inc. trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 78.5% during the 3rd quarter, according to its most recent 13F filing with the...
MarketBeat·2d ago
News Placeholder
Cardinal Health, Inc. $CAH Shares Sold by Campbell & CO Investment Adviser LLC
Campbell & CO Investment Adviser LLC lessened its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 51.9% during the 3rd quarter, according to the company in its most recent filing with the...
MarketBeat·2d ago
News Placeholder
Cardinal Health, Inc. (NYSE:CAH) Sees Large Growth in Short Interest
Cardinal Health, Inc. (NYSE:CAH - Get Free Report) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totaling 6,061,976...
MarketBeat·2d ago
News Placeholder
Nippon Life Global Investors Americas Inc. Trims Stake in Cardinal Health, Inc. $CAH
Nippon Life Global Investors Americas Inc. lowered its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 15.6% during the 3rd quarter, according to the company in its most recent filing...
MarketBeat·3d ago
News Placeholder
Top Analyst Reports for Visa, AMD & Thermo Fisher
Visa's volume-driven growth, cross-border expansion and AI investments support long-term prospects, but rising costs and regulatory risks keep the outlook cautious.
Zacks·4d ago
News Placeholder
Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results
ISRG posts strong preliminary Q4 and full-year 2025 revenue growth, but shares dip as investors weigh procedure trends, margins and outlook.
Zacks·4d ago
News Placeholder
DexCom Stock Declines Following Strong Preliminary Q4 Results
DXCM posts strong preliminary Q4 and full-year 2025 revenue growth, beating estimates, though shares slip after the announcement.
Zacks·4d ago
News Placeholder
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks·4d ago
News Placeholder
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Zacks·5d ago
<
1
2
...
>

Latest CAH News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.